prikaz prve stranice dokumenta Treatment of diabetic ketoacidosis associated with antipsychotic medication: literature review
  Preuzmi
PDF 261.72 KB
Znanstveni rad - Pregledni rad
Treatment of diabetic ketoacidosis associated with antipsychotic medication: literature review
Journal of Clinical Psychopharmacology, 37 (2017), 5; 584-589. https://doi.org/10.1097/JCP.0000000000000772
Vuk, Antonia; Baretić, Maja; Matovinović Osvatić, Martina; Filipčić, Igor; Jovanović, Nikolina; Rojnić Kuzman, Martina

Institucijski repozitorij: Dr Med - digitalni repozitorij Medicinskog fakulteta Sveučilišta u Zagrebu

Citirajte ovaj rad

Vuk, A., Baretić, M., Matovinović Osvatić, M., Filipčić, I., Jovanović, N. i Rojnić Kuzman, M. (2017). Treatment of diabetic ketoacidosis associated with antipsychotic medication: literature review. Journal of Clinical Psychopharmacology, 37. (5), 584-589. doi: 10.1097/JCP.0000000000000772

Vuk, Antonia, et al. "Treatment of diabetic ketoacidosis associated with antipsychotic medication: literature review." Journal of Clinical Psychopharmacology, vol. 37, br. 5, 2017, str. 584-589. https://doi.org/10.1097/JCP.0000000000000772

Vuk, Antonia, Maja Baretić, Martina Matovinović Osvatić, Igor Filipčić, Nikolina Jovanović i Martina Rojnić Kuzman. "Treatment of diabetic ketoacidosis associated with antipsychotic medication: literature review." Journal of Clinical Psychopharmacology 37, br. 5 (2017): 584-589. https://doi.org/10.1097/JCP.0000000000000772

Vuk, A., et al. (2017) 'Treatment of diabetic ketoacidosis associated with antipsychotic medication: literature review', Journal of Clinical Psychopharmacology, 37(5), str. 584-589. doi: 10.1097/JCP.0000000000000772

Vuk A, Baretić M, Matovinović Osvatić M, Filipčić I, Jovanović N, Rojnić Kuzman M. Treatment of diabetic ketoacidosis associated with antipsychotic medication: literature review. Journal of Clinical Psychopharmacology [Internet]. 10.2017. [pristupljeno 28.04.2024.];37(5):584-589. doi: 10.1097/JCP.0000000000000772

A. Vuk, M. Baretić, M. Matovinović Osvatić, I. Filipčić, N. Jovanović i M. Rojnić Kuzman, "Treatment of diabetic ketoacidosis associated with antipsychotic medication: literature review", Journal of Clinical Psychopharmacology, vol. 37, br. 5, str. 584-589, Listopad 2017. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:275105. [Citirano: 28.04.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:275105
Podaci o radu
Naslov (engleski)Treatment of diabetic ketoacidosis associated with antipsychotic medication: literature review
AutorAntonia Vuk
AutorMaja Baretić
AutorMartina Matovinović Osvatić
AutorIgor Filipčić
AutorNikolina Jovanović
AutorMartina Rojnić Kuzman
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Sažetak (engleski)
BACKGROUND: The second-generation antipsychotics (SGAs) are associated with metabolic disturbances. Diabetic ketoacidosis (DKA) is a rare, but potentially fatal sign of acute glucose metabolism dysregulation, which may be associated with the use of SGAs. This study aims to review published reports of patients with schizophrenia and antipsychotic drug-associated DKA, focusing on the effective management of both conditions. ----- METHODS: Using a predefined search strategy, we searched PubMed and EMBASE from their inception to July 2016. The search terms were related to "diabetic ketoacidosis" and "antipsychotic medication." Case reports, case series, and reviews of case series written in English language were included in the review. ----- RESULTS: Sixty-five reports were analyzed. In most patients who developed antipsychotic-associated DKA, 1 or more suspected antipsychotic medications were discontinued. In 5 cases, a rechallenge test was trialed, and in only 1 case, it resulted in the elevation of blood glucose. The majority was subsequently treated with a different SGA in combination with insulin/oral hypoglycemic agents; although approximately a third of patients had a complete resolution of symptoms or could control diabetes with diet only at the point of discharge. ----- CONCLUSIONS: Patients taking antipsychotic medications should be regularly screened for insulin resistance and educated about potential complications of antipsychotic medications. This will allow clinicians to individualize treatment decisions and reduce iatrogenic contribution to morbidity and mortality. To achieve best treatment outcomes, antipsychotic-induced DKA should be treated jointly by psychiatry and endocrinology teams.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Pregledni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaJournal of Clinical Psychopharmacology
Brojčani podacivol. 37, br. 5, str. 584-589
p-ISSN0271-0749
DOIhttps://doi.org/10.1097/JCP.0000000000000772
URN:NBNurn:nbn:hr:105:275105
Datum objave publikacije2017-10
URL dokumentahttps://doi.org/10.1097/JCP.0000000000000772
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2024-03-28 09:19:43